Sales Growth YoY (Last 12 Months): Immatics N.V. (IMTX)

Public company logo of Immatics Biotechnologies (IMTX)

Geopolitical fragmentation is limiting global clinical trials and biomaterial supplies for Immatics N.V. (IMTX). The TTM revenue growth rate helps distinguish temporary downturns from a systemic crisis, with the value of -44.00 reflecting this status. High R&D costs necessitate support from pharmaceutical partners, while real financial leverage will only emerge following drug approvals, once scaling eliminates the need for capital expenditures in laboratories.

Immatics (IMTX) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

Immatics (IMTX) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Immatics N.V.
Product sample of immatics.com

This indicator measures the rate of change in total revenue over the last twelve months on a daily basis, allowing for an assessment of the actual business scaling speed regardless of quarterly reporting. By analyzing the annual revenue growth over a rolling period, an investor can confirm the commercialization of the Immatics N.V. (IMTX) target discovery platform through the growth of partner payments and royalties.

Competitors of Immatics N.V. (IMTX)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XNCR (Xencor Corp)|Revenue Change YoY (Last 12 Months) CMPX|Sales Growth YoY (TTM) REPL (Replimune)|Revenue Dynamics YoY (Last Twelve Months) LYEL|innate-pharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Pyxis Oncology|Compugen Limited (CGEN) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)